Skip to main content
. 2023 Sep 13;15:38. doi: 10.1186/s13089-023-00336-3

Table 3.

Echocardiography parameters

Echoparameters N All Survived
n = 233
Non-survivor
n = 340
P-value
LV systolic function (Visual gestalt method) 540
Hyperdynamic 12 (2.22) 2 (0.94) 10 (3.05) 0.007
Good 341 (63.15) 142 (66.98) 199 (60.67)
Mildly reduced 47 (8.70) 21 (9.91) 26 (7.93)
Moderately reduced 93 (17.22) 39 (18.40) 54 (16.46)
Severely reduced 47 (8.70) 8 (3.77) 39 (11.89)
RWMA 506 90 (17.79) 24 (12.24) 66 (21.29) 0.010
LV diastolic function
E¥ (cm/sec) 215 79.43 (23.12) 83.51 (21.89) 76.60 (23.60) 0.030
A¥ (cm/sec) 202 75.83 (23.11) 71.02 (21.81) 79.18 (23.49) 0.013
E/A§ 202 1.01 (0.78–1.30) 1.14 (0.94–1.42) 0.91 (0.70–1.14)  < 0.001
e′ (cm/Sec) 208 10.27 (2.95) 10.84 (2.75) 9.88 (3.03) 0.021
E/e′§ 207 8.09 (2.65) 8.05 (2.59) 8.11 (2.69) 0.872
LV dilatation 573 251 (43.80) 109 (46.78) 142 (41.76) 0.235
RV dilatation 358 61 (17.04) 21 (15) 40 (18.35) 0.411
TAPSE (cm) 26 2.2 (1.8–2.4) 2.3 (1.8–2.56) 2.12 (1.7–2.3) 0.263
Troponin § (ng/ml) 281 0.06 (0.01–0.40) 0.03 (0.01–0.24) 0.07 (0.02–0.51) 0.015

Values are n (%), p value from Chi-square test of association. ¥Mean (SD), independent sample t-test was used for comparison. §Median (IQR), p value from Mann–Whitney U test, RWMA Regional wall motion abnormality, LV Left ventricle , RV Right ventricle, TAPSE Tricuspid annular plane systolic excursion